Migratory thrombophlebitis during sandostatin (SMS 201-995, Sandoz) therapy for malignant carcinoid syndrome

1989 ◽  
Vol 7 (2-3) ◽  
Author(s):  
Larry Nathanson ◽  
Alex Sochet ◽  
MaryEllen Williams
Keyword(s):  
Carcinoid Syndrome ◽  
Malignant Carcinoid ◽  
Malignant Carcinoid Syndrome

scholarly journals Successful treatment with a long-acting somatostatin analogue(SMS201-995) in a patient with malignant carcinoid syndrome.

1988 ◽  
Vol 27 (3) ◽  
pp. 311-316 ◽  
Author(s):  
Masayuki TSUDA ◽  
Shigehisa TAMAKI ◽  
Eiichi IWASAKI ◽  
Seikou MURASHIMA ◽  
Katsumi DEGUCHI ◽  
...  
Keyword(s):  
Successful Treatment ◽  
Carcinoid Syndrome ◽  
Somatostatin Analogue ◽  
Malignant Carcinoid ◽  
Malignant Carcinoid Syndrome ◽  
Long Acting

scholarly journals OBSERVATIONS ON A PATIENT WITH THE MALIGNANT CARCINOID SYNDROME

1959 ◽  
Vol 12 (4) ◽  
pp. 362-371 ◽  
Author(s):  
J. A. Kirkland ◽  
R. Cass ◽  
K. G. Lowe ◽  
S. F. Soutar
Keyword(s):  
Carcinoid Syndrome ◽  
Malignant Carcinoid ◽  
Malignant Carcinoid Syndrome

scholarly journals Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experience

2003 ◽  
Vol 17 (3) ◽  
pp. 437-444 ◽  
Author(s):  
J. Garland ◽  
J. R. Buscombe ◽  
C. Bouvier ◽  
P. Bouloux ◽  
M. H. Chapman ◽  
...  
Keyword(s):  
Carcinoid Syndrome ◽  
Malignant Carcinoid ◽  
Octreotide Acetate ◽  
Malignant Carcinoid Syndrome ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document